301103 何氏眼科
已收盘 05-17 15:00:00
资讯
新帖
简况
何氏眼科:沈阳何氏眼产业集团有限公司系公司实际控制人控制的关联方企业
证券之星 · 05-16 17:03
何氏眼科:沈阳何氏眼产业集团有限公司系公司实际控制人控制的关联方企业
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
证券之星 · 05-15
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
何氏眼科(301103)5月14日主力资金净买入207.15万元
证券之星 · 05-15
何氏眼科(301103)5月14日主力资金净买入207.15万元
何氏眼科(301103)5月10日主力资金净卖出1761.60万元
证券之星 · 05-13
何氏眼科(301103)5月10日主力资金净卖出1761.60万元
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
证券之星 · 05-09
何氏眼科:详见已回复过的相关问题,请您翻阅互动易
5月8日何氏眼科涨5.81%,申万菱信医药先锋股票A基金重仓该股
证券之星 · 05-08
5月8日何氏眼科涨5.81%,申万菱信医药先锋股票A基金重仓该股
山西证券:给予何氏眼科增持评级
证券之星 · 05-08
山西证券:给予何氏眼科增持评级
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
证券之星 · 05-06
何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息
何氏眼科(301103.SZ)累计回购1.32%股份 耗资5151.42万元
智通财经 · 05-06
何氏眼科(301103.SZ)累计回购1.32%股份 耗资5151.42万元
何氏眼科(301103.SZ)发一季度业绩,净利润2897.62万元,同比减少49.01%
智通财经 · 04-25
何氏眼科(301103.SZ)发一季度业绩,净利润2897.62万元,同比减少49.01%
何氏眼科:已回购1.04%股份 成交总金额约4071.09万元
中国财富通 · 04-23
何氏眼科:已回购1.04%股份 成交总金额约4071.09万元
何氏眼科(301103.SZ)已耗资4071.09万元回购1.04%股份
智通财经 · 04-23
何氏眼科(301103.SZ)已耗资4071.09万元回购1.04%股份
加载更多
公司概况
公司名称:
辽宁何氏眼科医院集团股份有限公司
所属行业:
卫生
上市日期:
2022-03-22
主营业务:
辽宁何氏眼科医院集团股份有限公司主营业务为面向眼病患者提供眼科专科诊疗服务和视光服务。公司的主要服务项目有白内障诊疗服务项目、屈光不正诊疗服务项目、玻璃体视网膜诊疗服务项目青光眼诊疗服务项目、干眼特色诊疗服务项目、中医特色诊疗服务项目。沈阳何氏眼科医院被评为“国家临床重点专科”、国际眼科理事会眼科专科医师培训基地、国家药物临床试验机构。
发行价格:
42.50
{"stockData":{"symbol":"301103","market":"SZ","secType":"STK","nameCN":"何氏眼科","latestPrice":25.27,"timestamp":1715929407000,"preClose":25.19,"halted":0,"volume":1238800,"delay":0,"floatShares":83090100,"shares":158000000,"eps":0.226,"marketStatus":"已收盘","marketStatusCode":5,"change":0.08,"latestTime":"05-17 15:00:00","open":25.21,"high":25.3,"low":24.9,"amount":31105800,"amplitude":0.0159,"askPrice":25.28,"askSize":9,"bidPrice":25.27,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.226,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":25.19,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":27.71,"lowLimit":22.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":158026471,"pbRate":1.92,"roa":"--","roe":"1.39%","epsLYR":0.4022,"committee":-0.296482,"marketValue":3993000000,"floatMarketCap":2100000000,"peRate":111.814161,"changeRate":0.0032,"turnoverRate":0.0149,"status":0},"requestUrl":"/m/hq/s/301103","defaultTab":"news","newsList":[{"id":"2435621278","title":"何氏眼科:沈阳何氏眼产业集团有限公司系公司实际控制人控制的关联方企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2435621278","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435621278?lang=zh_cn&edition=full","pubTime":"2024-05-16 17:03","pubTimestamp":1715850224,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月16日在投资者关系平台上答复投资者关心的问题。投资者:通报稿中:“何氏眼产业集团以高新技术为引领,打造了眼科机器人、生物药物、生物材料、干细胞治疗、基因治疗、合成生物学技术平台,自主研发的产品已销往全球87个国家和地区”。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051600025905.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435768419","title":"何氏眼科:详见已回复过的相关问题,请您翻阅互动易","url":"https://stock-news.laohu8.com/highlight/detail?id=2435768419","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435768419?lang=zh_cn&edition=full","pubTime":"2024-05-15 17:05","pubTimestamp":1715763958,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月15日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500029873.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435793875","title":"何氏眼科(301103)5月14日主力资金净买入207.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435793875","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435793875?lang=zh_cn&edition=full","pubTime":"2024-05-15 09:21","pubTimestamp":1715736099,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月14日收盘,何氏眼科报收于25.45元,下跌1.66%,换手率3.86%,成交量3.21万手,成交额8289.32万元。近5日资金流向一览见下表:何氏眼科融资融券信息显示,融资方面,当日融资买入801.27万元,融资偿还564.55万元,融资净买入236.72万元。何氏眼科主营业务:面向眼病患者提供眼科专科诊疗服务和视光服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500015459.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435036075","title":"何氏眼科(301103)5月10日主力资金净卖出1761.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435036075","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435036075?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:21","pubTimestamp":1715563318,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月10日收盘,何氏眼科报收于26.95元,下跌4.06%,换手率5.82%,成交量4.83万手,成交额1.34亿元。近5日资金流向一览见下表:何氏眼科融资融券信息显示,融资方面,当日融资买入625.73万元,融资偿还2314.04万元,融资净偿还1688.3万元。何氏眼科主营业务:面向眼病患者提供眼科专科诊疗服务和视光服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300001996.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434640580","title":"何氏眼科:详见已回复过的相关问题,请您翻阅互动易","url":"https://stock-news.laohu8.com/highlight/detail?id=2434640580","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434640580?lang=zh_cn&edition=full","pubTime":"2024-05-09 18:04","pubTimestamp":1715249049,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月09日在投资者关系平台上答复投资者关心的问题。此外,辽宁省细胞生物学学会服务站落户公司全资子公司本溪何氏眼科医院,服务站的建立将促进双方在眼科干细胞精准医疗等领域的深入长期合作,并提供技术资源支持,共同为推进眼科医疗尖端技术进步做出贡献。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900032907.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433711177","title":"5月8日何氏眼科涨5.81%,申万菱信医药先锋股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433711177","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433711177?lang=zh_cn&edition=full","pubTime":"2024-05-08 16:23","pubTimestamp":1715156626,"startTime":"0","endTime":"0","summary":"证券之星消息,5月8日何氏眼科涨5.81%,收盘报27.67元,换手率6.95%,成交量5.78万手,成交额1.57亿元。重仓何氏眼科的公募基金请见下表:该股最近90天内共有1家机构给出评级,增持评级1家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为申万菱信医药先锋股票A。申万菱信医药先锋股票A目前规模为2.13亿元,最新净值0.615,较上一交易日上涨0.97%,近一年下跌38.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800027502.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433762412","title":"山西证券:给予何氏眼科增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2433762412","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433762412?lang=zh_cn&edition=full","pubTime":"2024-05-08 10:55","pubTimestamp":1715136937,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司叶中正,魏赟,冯瑞近期对何氏眼科进行研究并发布了研究报告《疫后需求释放驱动2023业绩增长,高基数拖累2024Q1同比增速》,本报告对何氏眼科给出增持评级,当前股价为26.42元。考虑到公司的眼健康医疗服务已逐步恢复至正常水平,维持“增持-B”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800019054.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433447005","title":"何氏眼科:为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2433447005","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433447005?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:04","pubTimestamp":1714989897,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月06日在投资者关系平台上答复投资者关心的问题。投资者:请问截至2024年5月6日公司股东人数 谢谢何氏眼科董秘:尊敬的投资者您好,为保证所有投资者公平地获取公司的信息,公司在各期定期报告中会披露对应时点的股东信息。如确需查询其他时点的股东人数,根据相关法律法规规定,股东应当向公司提供证明其持有公司股份的种类以及持股数量的书面文件,公司经核实股东身份后按照股东的要求予以提供。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600020567.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433448631","title":"何氏眼科(301103.SZ)累计回购1.32%股份 耗资5151.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433448631","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433448631?lang=zh_cn&edition=full","pubTime":"2024-05-06 16:20","pubTimestamp":1714983631,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)公告,公司截至2024年4月30日以集中竞价交易方式已累计回购公司股份208.73万股,占公司当前总股本的1.32%,成交总金额为5151.42万元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117519.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430823812","title":"何氏眼科(301103.SZ)发一季度业绩,净利润2897.62万元,同比减少49.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430823812","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430823812?lang=zh_cn&edition=full","pubTime":"2024-04-25 23:26","pubTimestamp":1714058763,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)发布2024年第一季度报告,报告期内公司实现营业收入2.85亿元,同比减少7.18%;归属于上市公司股东的净利润2897.62万元,同比减少49.01%;归属于上市公司股东扣除非经常性损益净利润2834.40万元,同比减少48.62%;基本每股收益0.1834元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110924.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429158681","title":"何氏眼科:已回购1.04%股份 成交总金额约4071.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429158681","media":"中国财富通","top":-1,"share":"https://www.laohu8.com/m/news/2429158681?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:44","pubTimestamp":1713851094,"startTime":"0","endTime":"0","summary":"中国财富通4月23日 - 何氏眼科(301103)公告称,截至2024年4月22日,公司通过回购专用证券账户以集中竞价交易方式累计回购公司股份1,647,819股,占公司目前总股本的1.04%,最高成交价为31.36元/股,最低成交价为19.98元/股,成交总金额为40,710,889.37元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=wLcBbuWVTGE%3D","is_publish_highlight":false,"gpt_icon":0},{"id":"2429724139","title":"何氏眼科(301103.SZ)已耗资4071.09万元回购1.04%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2429724139","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429724139?lang=zh_cn&edition=full","pubTime":"2024-04-23 11:47","pubTimestamp":1713844061,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)发布公告,截至2024年4月22日,公司通过回购专用证券账户以集中竞价交易方式累计回购公司股份164.78万股,占公司目前总股本的1.04%,最高成交价为31.36元/股,最低成交价为19.98元/股,成交总金额为4071.09万元(不含交易费用)。本次回购符合公司回购股份方案及相关法律法规的要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107371.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-22","address":"辽宁省沈阳市浑南区天赐街5-1号(607)","stockEarnings":[{"period":"1week","weight":-0.0623},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.079},{"period":"6month","weight":-0.2407},{"period":"1year","weight":-0.4041},{"period":"ytd","weight":-0.1571}],"companyName":"辽宁何氏眼科医院集团股份有限公司","boardCode":"AI0083","perCapita":"7762股","boardName":"卫生","registeredCapital":"15802万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":" 辽宁何氏眼科医院集团股份有限公司主营业务为面向眼病患者提供眼科专科诊疗服务和视光服务。公司的主要服务项目有白内障诊疗服务项目、屈光不正诊疗服务项目、玻璃体视网膜诊疗服务项目青光眼诊疗服务项目、干眼特色诊疗服务项目、中医特色诊疗服务项目。沈阳何氏眼科医院被评为“国家临床重点专科”、国际眼科理事会眼科专科医师培训基地、国家药物临床试验机构。","serverTime":1716034879927,"listedPrice":42.5,"stockholders":"10704人(较上一季度增加3.05%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"何氏眼科,301103,何氏眼科股票,何氏眼科股票老虎,何氏眼科股票老虎国际,何氏眼科行情,何氏眼科股票行情,何氏眼科股价,何氏眼科股市,何氏眼科股票价格,何氏眼科股票交易,何氏眼科股票购买,何氏眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}